FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372637006: Heparinoid (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197931019 Heparinoid (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211165018 Heparinoid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
365341000195114 eparinoide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
815921000172112 héparinoïde fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3338761001000111 Heparinoid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Heparinoid (substance) Is a Direct acting anticoagulant (substance) true Inferred relationship Some
Heparinoid (substance) Is a Mucopolysaccharide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Glucurolactone Is a False Heparinoid (substance) Inferred relationship Some
Danaparoid (substance) Is a True Heparinoid (substance) Inferred relationship Some
Heparinoid adverse reaction (disorder) Causative agent (attribute) True Heparinoid (substance) Inferred relationship Some 1
Allergy to heparinoid (finding) Causative agent (attribute) False Heparinoid (substance) Inferred relationship Some
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Heparinoid (substance) Inferred relationship Some
Heparinoid 3 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Heparinoid (substance) Inferred relationship Some
Product containing heparinoid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid+hyaluronidase 50/150units/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Heparinoid (substance) Inferred relationship Some
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Heparinoid (substance) Inferred relationship Some
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Heparinoid (substance) Inferred relationship Some
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Heparinoid (substance) Inferred relationship Some
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Heparinoid (substance) Inferred relationship Some
Allergy to heparinoid (finding) Causative agent (attribute) True Heparinoid (substance) Inferred relationship Some 1
Danaparoid sodium (substance) Is a True Heparinoid (substance) Inferred relationship Some
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Heparinoid (substance) Inferred relationship Some 2
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Heparinoid (substance) Inferred relationship Some 2
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Heparinoid (substance) Inferred relationship Some 1
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Heparinoid (substance) Inferred relationship Some 1
Heparinoid 3 mg/g cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid 3 mg/g cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Heparinoid (substance) Inferred relationship Some 1
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Heparinoid (substance) Inferred relationship Some 1
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Heparinoid (substance) Inferred relationship Some 2
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Heparinoid (substance) Inferred relationship Some 2
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Heparinoid (substance) Inferred relationship Some 1
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid- and salicylic acid-containing product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid- and lauromacrogol 400-containing product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid- and lauromacrogol 400-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Product containing heparinoid and salicylic acid in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Product containing heparinoid in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid- and salicylic acid-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Product containing only heparinoid and lauromacrogol 400 (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid and salicylic acid only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid and lauromacrogol 400 only product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid and salicylic acid only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid and salicylic acid only product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Heparinoid (substance) Inferred relationship Some 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Heparinoid (substance) Inferred relationship Some 1
Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Heparinoid (substance) Inferred relationship Some 1
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Heparinoid (substance) Inferred relationship Some 1
Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Heparinoid (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start